Myriam Drysdale (Myriam Gharbi)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 31

Top Venues

BMC infectious diseases

Clinical drug investigation

Drug safety

BMJ open respiratory research

GlaxoSmithKline Plc

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GlaxoSmithKline Plc May 20 2017

United Kingdom

Manager Epidemiology :: Research and Development

Publications

Myriam Drysdale, Holly Tibble, Vishal Patel, Daniel C Gibbons, Emily J Lloyd, William Kerr, Calum Macdonald, Helen J Birch, Aziz Sheikh
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals, or no treatment: a retrospective cohort study. BMC infectious diseases 24 (1) (2024)
Diego F Wyszynski, Lydia Demetriou, Cheryl Renz, Shirin Aliabadi, Dragutin Rafailovic, Lee P Shulman, Myriam Drysdale, Keele E Wurst
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry. Drug safety 47 (9) (2024)
Myriam Drysdale, Evgeniy R Galimov, Marcus James Yarwood, Vishal Patel, Bethany Levick, Daniel C Gibbons, Jonathan D Watkins, Sophie Young, Benjamin F Pierce, Emily J Lloyd, William Kerr, Helen J Birch, Tahereh Kamalati, Stephen J Brett
Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study. BMJ open respiratory research 11 (1) (2024)
Myriam Drysdale, Evgeniy R Galimov, Marcus James Yarwood, Vishal Patel, Bethany Levick, Daniel C Gibbons, Jonathan D Watkins, Sophie Young, Benjamin F Pierce, Emily J Lloyd, William Kerr, Helen J Birch, Tahereh Kamalati, Stephen J Brett
Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study. BMJ open respiratory research 11 (1) (2024)
Diego F Wyszynski, Lydia Demetriou, Cheryl Renz, Shirin Aliabadi, Dragutin Rafailovic, Lee P Shulman, Myriam Drysdale, Keele E Wurst
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry. Drug safety (2024)
Christopher F Bell, Priyanka Jain, Raj Desai, Daniel C Gibbons, Myriam Drysdale, Maral DerSarkissian, Vishal Patel, Helen J Birch, Emily J Lloyd, Adina Zhang, Mei Sheng Duh, null null
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C). Clinical drug investigation 44 (3) (2024)
Myriam Drysdale, Thor Hautekiet, Moushmi Singh, Joris Hautekiet, Linda Ludikhuyze, Vishal Patel, Daniel C Gibbons, Dorothée De Roeck, Kirsten Colpaert, Emily J Lloyd, Eva Van Braeckel
Characteristics and outcomes of patients treated with sotrovimab to prevent progression to severe COVID-19 in Belgium. Acta clinica Belgica (2024)
Christopher F Bell, Priyanka Jain, Raj Desai, Daniel C Gibbons, Myriam Drysdale, Maral DerSarkissian, Vishal Patel, Helen J Birch, Emily J Lloyd, Adina Zhang, Mei Sheng Duh, null null
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C). Clinical drug investigation (2024)
Vishal Patel, Marcus J Yarwood, Bethany Levick, Daniel C Gibbons, Myriam Drysdale, William Kerr, Jonathan D Watkins, Sophie Young, Benjamin F Pierce, Emily J Lloyd, Helen J Birch, Tahereh Kamalati, Stephen James Brett
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England: a retrospective cohort study. Current medical research and opinion 40 (8) (2024)
Christopher F Bell, Priyanka Jain, Raj Desai, Daniel C Gibbons, Myriam Drysdale, Maral DerSarkissian, Vishal Patel, Helen J Birch, Emily J Lloyd, Adina Zhang, Mei Sheng Duh, null null
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C). Clinical drug investigation 44 (3) (2024)
Myriam Drysdale, Evgeniy R Galimov, Marcus James Yarwood, Vishal Patel, Bethany Levick, Daniel C Gibbons, Jonathan D Watkins, Sophie Young, Benjamin F Pierce, Emily J Lloyd, William Kerr, Helen J Birch, Tahereh Kamalati, Stephen J Brett
Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study. BMJ open respiratory research 11 (1) (2024)
Christopher F Bell, Priyanka Jain, Raj Desai, Daniel C Gibbons, Myriam Drysdale, Maral DerSarkissian, Vishal Patel, Helen J Birch, Emily J Lloyd, Adina Zhang, Mei Sheng Duh, null null
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C). Clinical drug investigation 44 (3) (2024)
Vishal Patel, Bethany Levick, Stephen Boult, Daniel C Gibbons, Myriam Drysdale, Emily J Lloyd, Moushmi Singh, Helen J Birch
Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England. BMC infectious diseases 24 (1) (2024)
Christopher F Bell, Priyanka Jain, Raj Desai, Daniel C Gibbons, Myriam Drysdale, Maral DerSarkissian, Vishal Patel, Helen J Birch, Emily J Lloyd, Adina Zhang, Mei Sheng Duh, null null
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C). Clinical drug investigation 44 (3) (2024)
Vishal Patel, Marcus J Yarwood, Bethany Levick, Daniel C Gibbons, Myriam Drysdale, William Kerr, Jonathan D Watkins, Sophie Young, Benjamin F Pierce, Emily J Lloyd, Helen J Birch, Tahereh Kamalati, Stephen James Brett
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England: a retrospective cohort study. Current medical research and opinion 40 (8) (2024)
Vishal Patel, Bethany Levick, Stephen Boult, Daniel C Gibbons, Myriam Drysdale, Emily J Lloyd, Moushmi Singh, Helen J Birch
Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England. BMC infectious diseases 24 (1) (2024)
Diego F Wyszynski, Lydia Demetriou, Cheryl Renz, Shirin Aliabadi, Dragutin Rafailovic, Lee P Shulman, Myriam Drysdale, Keele E Wurst
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry. Drug safety (2024)
Diego F Wyszynski, Lydia Demetriou, Cheryl Renz, Shirin Aliabadi, Dragutin Rafailovic, Lee P Shulman, Myriam Drysdale, Keele E Wurst
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry. Drug safety 47 (9) (2024)
Myriam Drysdale, Evgeniy R Galimov, Marcus James Yarwood, Vishal Patel, Bethany Levick, Daniel C Gibbons, Jonathan D Watkins, Sophie Young, Benjamin F Pierce, Emily J Lloyd, William Kerr, Helen J Birch, Tahereh Kamalati, Stephen J Brett
Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study. BMJ open respiratory research 11 (1) (2024)
Myriam Drysdale, Holly Tibble, Vishal Patel, Daniel C Gibbons, Emily J Lloyd, William Kerr, Calum Macdonald, Helen J Birch, Aziz Sheikh
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals, or no treatment: a retrospective cohort study. BMC infectious diseases 24 (1) (2024)
Vishal Patel, Marcus J Yarwood, Bethany Levick, Daniel C Gibbons, Myriam Drysdale, William Kerr, Jonathan D Watkins, Sophie Young, Benjamin F Pierce, Emily J Lloyd, Helen J Birch, Tahereh Kamalati, Stephen James Brett
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England: a retrospective cohort study. Current medical research and opinion (2024)
Vishal Patel, Bethany Levick, Stephen Boult, Daniel C Gibbons, Myriam Drysdale, Emily J Lloyd, Moushmi Singh, Helen J Birch
Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England. BMC infectious diseases 24 (1) (2024)
Myriam Drysdale, Thor Hautekiet, Moushmi Singh, Joris Hautekiet, Linda Ludikhuyze, Vishal Patel, Daniel C Gibbons, Dorothée De Roeck, Kirsten Colpaert, Emily J Lloyd, Eva Van Braeckel
Characteristics and outcomes of patients treated with sotrovimab to prevent progression to severe COVID-19 in Belgium. Acta clinica Belgica 79 (3) (2024)
Myriam Drysdale, Holly Tibble, Vishal Patel, Daniel C Gibbons, Emily J Lloyd, William Kerr, Calum Macdonald, Helen J Birch, Aziz Sheikh
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals, or no treatment: a retrospective cohort study. BMC infectious diseases 24 (1) (2024)
Diego F Wyszynski, Lydia Demetriou, Cheryl Renz, Shirin Aliabadi, Dragutin Rafailovic, Lee P Shulman, Myriam Drysdale, Keele E Wurst
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry. Drug safety 47 (9) (2024)
Myriam Drysdale, Thor Hautekiet, Moushmi Singh, Joris Hautekiet, Linda Ludikhuyze, Vishal Patel, Daniel C Gibbons, Dorothée De Roeck, Kirsten Colpaert, Emily J Lloyd, Eva Van Braeckel
Characteristics and outcomes of patients treated with sotrovimab to prevent progression to severe COVID-19 in Belgium. Acta clinica Belgica 79 (3) (2024)
Myriam Drysdale, Mehmet Berktas, Daniel C Gibbons, Catherine Rolland, Louis Lavoie, Emily J Lloyd
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance: a systematic literature review. Infection (2024)
Myriam Drysdale, Daniel C Gibbons, Moushmi Singh, Catherine Rolland, Louis Lavoie, Andrew Skingsley, Emily J Lloyd
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 subvariant predominance: a systematic literature review. Infection (2023)
Myriam Drysdale, Lionel K K Tan, Ana Martin, Isabelle Borghini Fuhrer, Stephan Duparc, Hema Sharma
Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review. Infectious diseases and therapy (2022)
Christianne Micallef, Monsey McLeod, Enrique Castro-Sánchez, Myriam Drysdale, Esmita Charani, Luke Stephen Prockter Moore, Mark Gilchrist, Fran Husson, Céire E Costelloe, Alison Helen Holmes
An Evidence-Based Antimicrobial Stewardship Smartphone App for Hospital Outpatients: Survey-based Needs Assessment Among Patients. JMIR mHealth and uHealth 4 (3) (2016)
Myriam Drysdale, Luke S P Moore, Enrique Castro-Sánchez, Elpiniki Spanoudaki, Charlotte Grady, Alison H Holmes, Lydia N Drumright
A needs assessment study for optimising prescribing practice in secondary care junior doctors: the Antibiotic Prescribing Education among Doctors (APED). BMC infectious diseases 16 (1) (2016)

Myriam Drysdale.css-eqlu8i{font-size:small;padding-left:4px;} (Myriam Gharbi)

Publication Activity (10 Years)

Top Topics

Top Venues

Myriam Drysdale (Myriam Gharbi)